UNSPSC 51102826: Ciprofloxacin/dextrose

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM900. This VA Drug Class (AM900) classifies this compound as belonging to the group ANTI-INFECTIVES, OTHER.

UNSPSC 51102826 Ciprofloxacin/dextrose is a Commodity code representing intravenous antibiotic solutions and related pharmaceutical preparations that state and local health departments and public health agencies procure for emergency stockpiles, disease treatment protocols, and public health response. The code captures individual drug products — in this case, ciprofloxacin formulations combined with dextrose — rather than broader antibiotic families or pharmaceutical categories. State and local issuers procuring under this code are primarily state health departments, county health departments, and public health districts managing controlled pharmaceutical inventory for epidemiological readiness and treatment delivery.

Recent activity under the code is limited but concrete. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392, IFB process) for Ciprofloxacin Hydrochloride 500mg tablets in 20-count packages with 60-month product expiration, alongside doxycycline hyclate; the contract award totals $2,999,999.11 over 12 months with two one-year renewal options. The second identified opportunity — Seminole County, Florida (IFB60459723LAS, due July 26, 2023) — pursued naloxone and drug deactivation systems rather than ciprofloxacin and is unrelated to this Commodity code's scope. Geographic activity is concentrated in Illinois; the source provides no evidence of procurement activity in other states under this specific code. The Illinois Department of Public Health remains the only identified recent buyer.